node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
CDK2 | FCHSD2 | ENSP00000266970 | ENSP00000386722 | cyclin-dependent kinase 2; Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and [...] | FCH and double SH3 domains 2 | 0.506 |
CDK2 | SORBS1 | ENSP00000266970 | ENSP00000355136 | cyclin-dependent kinase 2; Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and [...] | sorbin and SH3 domain containing 1 | 0.516 |
CDK2 | SPG20 | ENSP00000266970 | ENSP00000347314 | cyclin-dependent kinase 2; Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and [...] | spastic paraplegia 20 (Troyer syndrome); May be implicated in endosomal trafficking, or microtubule dynamics, or both | 0.568 |
CDK2 | STAC | ENSP00000266970 | ENSP00000273183 | cyclin-dependent kinase 2; Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and [...] | SH3 and cysteine rich domain; Probably involved in a neuron-specific signal transduction | 0.474 |
CDK2 | TRIM45 | ENSP00000266970 | ENSP00000256649 | cyclin-dependent kinase 2; Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and [...] | tripartite motif containing 45; May act as a transcriptional repressor in mitogen- activated protein kinase signaling pathway | 0.630 |
CDK2 | UEVLD | ENSP00000266970 | ENSP00000379500 | cyclin-dependent kinase 2; Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and [...] | UEV and lactate/malate dehyrogenase domains; Possible negative regulator of polyubiquitination | 0.568 |
FCHSD2 | CDK2 | ENSP00000386722 | ENSP00000266970 | FCH and double SH3 domains 2 | cyclin-dependent kinase 2; Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and [...] | 0.506 |
FCHSD2 | KIR2DL1 | ENSP00000386722 | ENSP00000336769 | FCH and double SH3 domains 2 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1; Receptor on natural killer (NK) cells for HLA-C alleles. Inhibits the activity of NK cells thus preventing cell lysis | 0.416 |
FCHSD2 | KIR2DL2 | ENSP00000386722 | ENSP00000383672 | FCH and double SH3 domains 2 | killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1; Receptor on natural killer (NK) cells for HLA-C alleles. Does not inhibit the activity of NK cells | 0.535 |
FCHSD2 | SORBS1 | ENSP00000386722 | ENSP00000355136 | FCH and double SH3 domains 2 | sorbin and SH3 domain containing 1 | 0.659 |
FCHSD2 | SPG20 | ENSP00000386722 | ENSP00000347314 | FCH and double SH3 domains 2 | spastic paraplegia 20 (Troyer syndrome); May be implicated in endosomal trafficking, or microtubule dynamics, or both | 0.729 |
FCHSD2 | STAC | ENSP00000386722 | ENSP00000273183 | FCH and double SH3 domains 2 | SH3 and cysteine rich domain; Probably involved in a neuron-specific signal transduction | 0.722 |
FCHSD2 | TRIM45 | ENSP00000386722 | ENSP00000256649 | FCH and double SH3 domains 2 | tripartite motif containing 45; May act as a transcriptional repressor in mitogen- activated protein kinase signaling pathway | 0.815 |
FCHSD2 | UEVLD | ENSP00000386722 | ENSP00000379500 | FCH and double SH3 domains 2 | UEV and lactate/malate dehyrogenase domains; Possible negative regulator of polyubiquitination | 0.757 |
KIR2DL1 | FCHSD2 | ENSP00000336769 | ENSP00000386722 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1; Receptor on natural killer (NK) cells for HLA-C alleles. Inhibits the activity of NK cells thus preventing cell lysis | FCH and double SH3 domains 2 | 0.416 |
KIR2DL1 | SORBS1 | ENSP00000336769 | ENSP00000355136 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1; Receptor on natural killer (NK) cells for HLA-C alleles. Inhibits the activity of NK cells thus preventing cell lysis | sorbin and SH3 domain containing 1 | 0.643 |
KIR2DL1 | SPG20 | ENSP00000336769 | ENSP00000347314 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1; Receptor on natural killer (NK) cells for HLA-C alleles. Inhibits the activity of NK cells thus preventing cell lysis | spastic paraplegia 20 (Troyer syndrome); May be implicated in endosomal trafficking, or microtubule dynamics, or both | 0.637 |
KIR2DL1 | STAC | ENSP00000336769 | ENSP00000273183 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1; Receptor on natural killer (NK) cells for HLA-C alleles. Inhibits the activity of NK cells thus preventing cell lysis | SH3 and cysteine rich domain; Probably involved in a neuron-specific signal transduction | 0.472 |
KIR2DL1 | TRIM45 | ENSP00000336769 | ENSP00000256649 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1; Receptor on natural killer (NK) cells for HLA-C alleles. Inhibits the activity of NK cells thus preventing cell lysis | tripartite motif containing 45; May act as a transcriptional repressor in mitogen- activated protein kinase signaling pathway | 0.646 |
KIR2DL1 | UEVLD | ENSP00000336769 | ENSP00000379500 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1; Receptor on natural killer (NK) cells for HLA-C alleles. Inhibits the activity of NK cells thus preventing cell lysis | UEV and lactate/malate dehyrogenase domains; Possible negative regulator of polyubiquitination | 0.569 |